Cost-effectiveness of ceftazidime/avibactam for infections due to carbapenem-resistant bacteria in Peru

Rafael Bolanõs-Diáz, Eddie Angles-Yanqui, Giancarlo Perez-Lazo, Cesar Sanabria-Montañez

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-effectiveness of ceftazidime/avibactam for infections due to carbapenem-resistant bacteria in Peru'. Together they form a unique fingerprint.

Business & Economics

Medicine & Life Sciences

Chemical Compounds